The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.538%)
Open: 32.75
High: 33.00
Low: 32.50
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction: Appointment and Issue of Shares

29 Oct 2015 07:00

RNS Number : 7859D
Duke Royalty Limited
29 October 2015
 



29 October 2015

This announcement replaces the Company's announcement issued under RNS number 6322D at 07.00 on 28 October 2015 (the "Previous Announcement"). The Previous Announcement stated that following the Share Issue, Mr Cochrane will hold 250,000 Ordinary Shares, representing 3.17 per cent of the entire issued share capital. The Previous Announcement should have stated that following the Share Issue, Mr Cochrane will hold 300,000 Ordinary Shares, representing 3.81 per cent of the entire issued share capital.

The full amended announcement is set out below. All other details remain unchanged.

Duke Royalty Limited

("Duke Royalty" or the "Company")

 

Correction: Mr Justin Cochrane Appointment and Issue of Shares

 

Duke Royalty is pleased to announce that Justin Cochrane, a current member of the Company's Healthcare Investment Committee, has agreed to join Abingdon Capital Corporation ('Abingdon') as Executive Vice President, Corporate Development on a full time basis. Abingdon is a financial advisory company, which provides support services to the Company in respect of global deal origination, vertical partner relationships and on-going investment management, including preparation of investment reports, performance data and compliance with the Company's investing policy. Through his position at Abingdon, Mr Cochrane will play a pivotal role in the roll-out and execution of the Duke Royalty business plan and will bring significant royalty based experience to the operational team.

Mr Cochrane has negotiated, structured and executed dozens of royalty transactions in multiple jurisdictions during his five years at Sandstorm Gold Limited where he was Executive Vice President of Corporate Development. From 2002 to 2010 Mr Cochrane worked for National Bank Financial Inc. where he gained significant transaction experience executing M&A and capital markets transactions including IPO's for the income trust and royalty sectors, among others. Mr Cochrane holds a Bachelor of Commerce (finance major) from the University of British Columbia and has received a CFA designation from the CFA Institute.

In his new role, Mr Cochrane will have an active involvement in the due diligence of prospective investment opportunities for Duke Royalty; assisting in the execution of royalty transactions approved by the Duke Royalty board and in the monitoring of royalty investments made by the Company.

The Duke Royalty Board has approved the issue of 250,000 new Duke Royalty ordinary shares of no par value each in the Company ("Ordinary Shares") to Mr Cochrane (the "Share Issue") as a signing bonus, further cementing his alignment with shareholders.

Application has been made for the 250,000 new Ordinary Shares to be admitted to trading on AIM with admission expected to take place on or around 3 November 2015 ("Admission").

Following the Share Issue, Mr Cochrane will hold 300,000 Ordinary Shares, representing 3.81 per cent of the entire issued share capital.

Following Admission, there will be 7,877,459 Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 7,877,459. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information:

Duke Royalty Limited

Neil Johnson

Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson/ Jamie Barklem/ Daniel Bush

+44 (0)20 7383 5100

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited is a team of experienced financial executives dedicated to providing royalty financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty has reinvented the royalty financing model for the European public markets through its efficient corporate structure and exclusive alliances and partnerships that provide both deal flow and expertise. Duke Royalty's investments are intended to provide robust, stable, long-term returns to its shareholders.

 

Duke Royalty is listed on the AIM market under the ticker DUKE. For more information, visit dukeroyalty.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEDFAAFISEIS
Date   Source Headline
22nd Mar 20197:00 amRNSDirector's Dealings
19th Mar 20197:00 amRNSDividend Declaration
14th Mar 20197:00 amRNSChange of Adviser
19th Feb 20197:00 amRNSNew Royalty Finance Agreement
5th Feb 20191:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider
17th Dec 20187:00 amRNSFollow-on contribution to royalty partner
5th Dec 20187:00 amRNSIssue of Shares and Total Voting Rights
4th Dec 20187:00 amRNSInterim results and dividend declaration
27th Nov 201811:31 amRNSDuke Royalty to Present at Mello London
31st Oct 20187:00 amRNSLTIP Awards and other Issuances
30th Oct 20187:00 amRNSOperational and Corporate Update
28th Sep 20187:00 amRNSFurther Contribution to Royalty Partner
24th Sep 20187:00 amRNSFinal Results and Notice of AGM
20th Sep 20187:00 amRNSDividend Declaration and Notice of Results
30th Aug 20187:00 amRNSNew Royalty Agreement
6th Aug 20184:50 pmRNSNotification of major holdings
6th Aug 20184:45 pmRNSNotification of major holdings
6th Aug 20183:18 pmRNSHolding(s) in Company
6th Aug 20181:18 pmRNSNotification of Major Holdings
2nd Aug 201812:20 pmRNSResult of EGM and Issue of Equity
16th Jul 20187:00 amRNSFundraising to raise £44m and EGM announcement
13th Jul 20184:56 pmRNSFundraising to raise £44 million and notice of EGM
19th Jun 20187:00 amRNSInterim Dividend Increase
14th Jun 20187:01 amRNSRoyalty finance agreement LOI and secured loan
14th Jun 20187:00 amRNSUpdate on Exclusive Collaboration
8th May 20187:00 amRNSOperational Update on Royalty Partners
26th Apr 20187:00 amRNSFurther Contribution to Royalty Partner
24th Apr 20187:00 amRNSNew Royalty Agreement
16th Apr 20181:34 pmRNSDuke Royalty at Berenberg UK Corporate Conference
13th Mar 20187:00 amRNSInterim Dividend Increase & Dividend Declaration
8th Mar 20187:00 amRNSDirector/PDMR Shareholdings
6th Mar 20187:00 amRNSLong Term Incentive Plan Awards
5th Mar 20187:00 amRNSNew Royalty Finance Agreement
27th Feb 20187:00 amRNSDuke Royalty Appoints Redleaf Communications
2nd Jan 20184:51 pmRNSHolding(s) in Company
22nd Dec 201712:09 pmRNSHolding(s) in Company
21st Dec 201710:36 amRNSResult of EGM and Issue of Equity
19th Dec 201712:49 pmRNSInterim Dividend
5th Dec 20173:18 pmRNSResult of the Fundraising and Notice of EGM
4th Dec 20174:48 pmRNSProposed Fundraising to raise at least £20 million
13th Nov 20179:39 amRNSFurther Contribution to Royalty Partner
8th Nov 20177:05 amRNSUnaudited Interim Results
8th Nov 20177:00 amRNSStrategic Advisory Agreement
9th Oct 201711:01 amRNSDirector/PDMR Shareholding
6th Oct 20177:00 amRNSNew Royalty Finance Agreement
28th Sep 20172:47 pmRNSBoard changes and investment team addition
27th Sep 201711:46 amRNSResult of AGM
21st Sep 20173:14 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSChange of Adviser and Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.